GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (OTCPK:RGEDF) » Definitions » Days Sales Outstanding

RGEDF (Chemical Works of Gedeon Richter) Days Sales Outstanding : 96.82 (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Chemical Works of Gedeon Richter Days Sales Outstanding?

Chemical Works of Gedeon Richter's average Accounts Receivable for the three months ended in Mar. 2025 was $693 Mil. Chemical Works of Gedeon Richter's Revenue for the three months ended in Mar. 2025 was $653 Mil. Hence, Chemical Works of Gedeon Richter's Days Sales Outstanding for the three months ended in Mar. 2025 was 96.82.

The historical rank and industry rank for Chemical Works of Gedeon Richter's Days Sales Outstanding or its related term are showing as below:

RGEDF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 81.83   Med: 97.71   Max: 196.07
Current: 196.07

During the past 13 years, Chemical Works of Gedeon Richter's highest Days Sales Outstanding was 196.07. The lowest was 81.83. And the median was 97.71.

RGEDF's Days Sales Outstanding is ranked worse than
93.36% of 949 companies
in the Drug Manufacturers industry
Industry Median: 72.66 vs RGEDF: 196.07

Chemical Works of Gedeon Richter's Days Sales Outstanding increased from Dec. 2023 (92.06) to Mar. 2025 (96.82).


Chemical Works of Gedeon Richter Days Sales Outstanding Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Days Sales Outstanding Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.88 97.65 81.83 86.17 94.77

Chemical Works of Gedeon Richter Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.06 91.94 98.79 - 96.82

Competitive Comparison of Chemical Works of Gedeon Richter's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemical Works of Gedeon Richter's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's Days Sales Outstanding falls into.


;
;

Chemical Works of Gedeon Richter Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Chemical Works of Gedeon Richter's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (597.173 + 700.191) / 2 ) / 2498.452*365
=648.682 / 2498.452*365
=94.77

Chemical Works of Gedeon Richter's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (700.191 + 684.84) / 2 ) / 652.693*365 / 4
=692.5155 / 652.693*365 / 4
=96.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chemical Works of Gedeon Richter  (OTCPK:RGEDF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Chemical Works of Gedeon Richter Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Chemical Works of Gedeon Richter Business Description

Traded in Other Exchanges
Address
Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.